2019-2022, NHS Tayside Principle Investigator CARBAR study (a retrospective study to evaluate the epidemiology, standard of care, outcomes and resource use associated with patients who have, or are at risk of, infection with carbapenem non-susceptible gram-negative organisms of interest (Enterobacteriacae, Pseudomonas, Stenotrophomonas and Acinetobacter)).